Methicillin-Resistant Staphylococcus aurous: Epidemiology,  Transmission and New Alternative Therapies: A Narrative Review

Nouha  Bouali; Najla  Haddaji; Walid Sari  Hamadou; Mouna  Ghorbel; Olfa Bechambi; Abdelkarim  Mahdhi; Majdi  Snoussi

doi:10.18502/ijph.v52i8.13395

Nouha Bouali Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia
Najla Haddaji Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia
Walid Sari Hamadou Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia
Mouna Ghorbel Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia
Olfa Bechambi Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia
Abdelkarim Mahdhi Laboratory of Analysis, Treatment and Valorization of Pollutants of the Environment and Products, Faculty of Pharmacy, Univer-sity of Monastir, Tunisia
Majdi Snoussi Department of Biology, College of Science, University of Ha’il, Ha’il, Saudi Arabia

DOI: https://doi.org/10.18502/ijph.v52i8.13395

Keywords: Methicillin-resistant Staphylococcus aureus (MRSA), Alternative treatments

Abstract

Over the last decade, we were facing medical struggle by the emergence of multi-resistant bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA). MRSA infections are still causing a growing global concern due to the rapid adaptive multidrug resistance to conventional antibiotics in human, community and veterinary medicine. Here we provide an overview about MRSA epidemiology, transmission and alternative potential treatments particularly new discovered phytochemicals with biological activity. In this narrative review, bibliographic data was collected from literature search databases: Google Scholar, web of science and PubMed/MEDLINE during recent years (2016 to 2021). MRSA is responsible of wide spectrum life threatening infections such us septicemia, endocarditis, and wound infections. It has epidemic potential in hospitals, that is responsible of most nosocomial infections leading to mortality and constitute a real burden for the healthcare systems. Effective preventive strategies for management of MRSA are highly required moreover, the identification and development of novel drugs or active biomolecules through phytochemicals are time challenging to face new resistant strains.